Insulin-like growth factors I and II comprise a structurally-related pair of circulating proteins of fundamental importance in mammalian growth and development. Although much evidence has accumulated supporting a major role for IGF-I as a postnatal growth factor, regulated at least in part by growth hormone, many studies suggest a broader range of functions for this peptide, including actions on fetal growth and on cell and tissue differentiation. These observations in turn imply that the control of IGF-I synthesis may be multifactorial, responding not only to hormonal signals but also to tissue- and developmentally-specific factors, and that regulation may occur at multiple levels, including gene transcription, RNA processing, and protein biosynthesis. As part of a long-term goal to understand the mechanisms by which IGF-I synthesis is controlled, the focus of this application will be on the regulation of IGF-I gene expression, and, in particular, on the signal transduction pathways and nuclear factors that mediate IGF-I gene transcription under different physiological and developmental conditions. Toward this end the following specific aims are proposed: 1. To determine the signaling pathways and molecular mechanisms by which growth hormone rapidly activates IGF-I gene transcription. 2. To define the mechanisms responsible for the stepwise induction of IGF- I gene expression during fetal and early postnatal development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK037449-11
Application #
2391388
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Sato, Sheryl M
Project Start
1986-09-01
Project End
1999-03-31
Budget Start
1997-07-28
Budget End
1998-03-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Woelfle, Joachim; Rotwein, Peter (2004) In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286:E393-401
Woelfle, Joachim; Billiard, Julia; Rotwein, Peter (2003) Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 278:22696-702
Billiard, J; Umayahara, Y; Wiren, K et al. (2001) Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts. J Biol Chem 276:15354-61
Billiard, J; Grewal, S S; Lukaesko, L et al. (2001) Hormonal control of insulin-like growth factor I gene transcription in human osteoblasts: dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta. J Biol Chem 276:31238-46
Umayahara, Y; Billiard, J; Ji, C et al. (1999) CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. J Biol Chem 274:10609-17
Le Stunff, C; Rotwein, P (1998) Growth hormone stimulates interferon regulatory factor-1 gene expression in the liver. Endocrinology 139:859-66
Umayahara, Y; Ji, C; Centrella, M et al. (1997) CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J Biol Chem 272:31793-800
Ye, P; Umayahara, Y; Ritter, D et al. (1997) Regulation of insulin-like growth factor I (IGF-I) gene expression in brain of transgenic mice expressing an IGF-I-luciferase fusion gene. Endocrinology 138:5466-75
McCarthy, T L; Ji, C; Shu, H et al. (1997) 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures. J Biol Chem 272:18132-9
Bui, T; Kuo, C; Rotwein, P et al. (1997) Prostaglandin A2 specifically represses insulin-like growth factor-I gene expression in C6 rat glioma cells. Endocrinology 138:985-93

Showing the most recent 10 out of 44 publications